AC Immune S.A.
ACIU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$51 | -$54 | -$71 | -$73 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $4 | $3 | $4 |
| Change in WC | $108 | -$15 | -$8 | $7 |
| Other Non-Cash | $2 | $2 | -$0 | -$6 |
| Operating Cash Flow | $66 | -$60 | -$74 | -$66 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$1 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$105 | $66 | $25 | -$51 |
| Investing Cash Flow | -$105 | $66 | $24 | -$54 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | -$1 | $23 |
| Stock Issued | $0 | $44 | $0 | $18 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $0 | -$1 | -$0 |
| Financing Cash Flow | -$1 | $43 | -$1 | $41 |
| Forex Effect | -$2 | -$2 | $1 | -$0 |
| Net Chg. in Cash | -$42 | $47 | -$51 | -$79 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $78 | $32 | $82 | $161 |
| End Cash | $36 | $78 | $32 | $82 |
| Free Cash Flow | $65 | -$61 | -$75 | -$68 |